Published in Oncology on January 01, 1980
The structural basis of the functioning of bacteriorhodopsin: an overview. FEBS Lett (1979) 4.30
Recent findings in the structure-functional characteristics of bacteriorhodopsin. FEBS Lett (1977) 0.99
Products of limited proteolysis of bacteriorhodopsin generate a membrane potential. FEBS Lett (1978) 0.99
Comparison of 5-fluorouracil and ftorafur. I. Quantitative and qualitative differences in toxicity to mice. Cancer Treat Rep (1976) 0.83
[Neutron activation analysis in the pharmacokinetics of cis-dichlorodiammineplatinum (experimental studies)]. Med Radiol (Mosk) (1980) 0.81
CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients. Adv Exp Med Biol (1999) 0.81
Markers of type D retroviruses in children with Burkitt's-type lymphoma. Immunol Lett (1996) 0.79
[Molecular genetic basis of proximal spinal muscular atrophy and experience in its pharmaceutical treatment]. Genetika (2008) 0.78
[Analysis of deletional damage in SMN1, SMN2, and NAIP genes in patients with spinal muscular atrophy in the northwestern region of Russia]. Genetika (2001) 0.77
Effects of physicochemical forms of phenazepam and Panavir on their action at ultra-low doses. Bull Exp Biol Med (2012) 0.77
Type D retrovirus specific sequences in lymphocytes of the children with Burkitt-type lymphoma and their parents. Immunol Lett (2001) 0.76
[Expression of the human dystrophin gene in mdx mouse muscle fibers after transfection using liposomes and synthetic oligopeptides]. Genetika (1998) 0.75
[The cytotoxicity of Chamaenerium angustifolium (L.) Scop. and Hippophae rhamnoides L. tannins and their effect on mitochondrial respiration]. Eksp Klin Farmakol (1997) 0.75
[Pharmacokinetics of n-(5-oxynicotinoyl)-L-glutamic acid calcium salt upon bolus administration in rats and rabbits: interspecies extrapolation]. Eksp Klin Farmakol (2010) 0.75
Two different anti-erythroid monoclonal antibodies in immunodiagnosis of human leukemias: a comparative study. Int J Cancer (1989) 0.75
[Lymphosarcoma of the oropharynx and nasopharynx in children]. Pediatriia (1991) 0.75
[Obtaining and study of asalei and asalin suspensions]. Farmatsiia (1971) 0.75
[Interferon and tactivin in the treatment program for non-Hodgkin's lymphomas in children during remission]. Vopr Onkol (1995) 0.75
[Dendrimers based lysine and their "starburst" polymeric derivatives: prospects of use in compacting DNA and in vitro delivery of genetic constructs]. Bioorg Khim (2004) 0.75
[Regression of rat sarcoma 45 at single administration of sarcolysine, asalin and asalei]. Farmakol Toksikol (1970) 0.75
[Features of transfection and expression of cDNA for the human dystrophin gene, delivered into muscles of mdx mice using MF-2 synthetic microspheres]. Genetika (1999) 0.75
[Cationic oligopeptides modified with lipophilic fragments: use for DNA delivery to cells]. Bioorg Khim (2005) 0.75
[Central hemodynamic changes in children with locomotor system diseases during surgery and anesthesia]. Anesteziol Reanimatol (1998) 0.75
[Results of using Solanum tuberosum sprouts extract for the treatment of ophthalmoherpes]. Eksp Klin Farmakol (2015) 0.75
[Dynamics of toxic manifestations and antineoplastic effect of dactinomycin after single-dose administration]. Antibiotiki (1971) 0.75
[Some pharmacological properties of fluorodopan]. Farmakol Toksikol (1971) 0.75
[Diagnostic criteria and prognosis of mediastinal lesions in children with lymphosarcoma]. Vopr Onkol (1997) 0.75
[Erythroid antigens in children with hemoblastoses]. Sov Med (1988) 0.75
[Clinico-immunological characteristics of lymphoid tumors in children]. Vestn Ross Akad Med Nauk (2002) 0.75
[Morpho-ecological characteristics of thyroid diseases in various regions of Russia and Belorussia from surgical data]. Arkh Patol (2000) 0.75
[Potentiation by blastolysin of the effect of cyclophosphamide in preventing recurrence in mouse T-cell leukemia]. Biull Eksp Biol Med (1984) 0.75
[Diagnosis and treatment of large-cell anaplastic lymphoma in children]. Vestn Ross Akad Med Nauk (2000) 0.75
[Ecological and hygienic markers in evidence-based medicine]. Gig Sanit (2005) 0.75
[Mitigation of cisplatin toxicity by the complexon tetacin-calcium]. Eksp Onkol (1985) 0.75
[Results of removing traumatic cataracts in children by the lensectomy method]. Oftalmol Zh (1986) 0.75
[Morphoecological characterization of thyroid diseases endemic in Nizhegorodskaya region (resected material data)]. Vopr Onkol (2009) 0.75
[Immunologic prognosis in hemoblastoses in children]. Vopr Onkol (1990) 0.75
[Pharmacological properties of 20 antibiotic isolated from Aspergillus fumigatus]. Antibiotiki (1969) 0.75
[Effects of changes in body posture on hemodynamics in patients with infantile cerebral palsy during general anesthesia with preservation of spontaneous respiration]. Anesteziol Reanimatol (1999) 0.75
Production of intense low-energy positron beams with synchrotron radiation. J Synchrotron Radiat (1996) 0.75
[Toxicological properties of fentirin]. Farmakol Toksikol (1980) 0.75
[Organizational and methodical aspects of the use of a methodology for the assessment of risk in the practical activity of sanitary-epidemiological services]. Gig Sanit (2003) 0.75
[Immune status of patients with exacerbation of chronic suppurative otitis media and its correction]. Vestn Otorinolaringol (2010) 0.75
[Effect of 5-fluorouracil on food requirement, body and organ growth in rats]. Farmakol Toksikol (1969) 0.75
[Effect of phenobarbital and SKF 525-A on the toxic and therapeutic action of adriamycin in mice with Ehrlich ascites cancer]. Eksp Onkol (1985) 0.75
The bacteriorhodopsin proton pump: effect of crosslinkings of lysine residues. Arch Biochem Biophys (1988) 0.75
[Lysine dendrimers as vectors for delivering genetic constructs to eukaryotic cells]. Genetika (2007) 0.75
[Changes in the activity of nonspecific liver oxidases after surgery for cancer in children]. Pediatriia (1982) 0.75
[Evaluating the effectiveness of Solanum tuberosum shoots extract in experimental ocular herpes]. Vestn Oftalmol (2015) 0.75
The rate of cyclophosphamide activation. Neoplasma (1970) 0.75
[Radiobiological analysis of the antineoplastic action of sarcolysine]. Med Radiol (Mosk) (1982) 0.75
[Time factor in evaluating antineoplastic agents]. Farmakol Toksikol (1972) 0.75
[Activity of nonspecific hepatic oxidases and the biological effects of the antineoplastic antibiotic adriamycin]. Biull Eksp Biol Med (1981) 0.75
[Lymphosarcoma of the stomach in children]. Vopr Onkol (1992) 0.75
[Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)]. Vestn Akad Med Nauk SSSR (1984) 0.75
[Antineoplastic and toxic effects of blastolysin in the treatment of spontaneous mammary cancer in dogs]. Eksp Onkol (1984) 0.75
[Results of endothelial microscopy in patients with traumatic cataracts after lensectomy with implantation of intraocular lenses through the flat part of the ciliary body]. Vestn Oftalmol (1986) 0.75
The treatment of hypertrophy of the prostate of rats with 4-nitro-3-trifluoromethylisobutyranilide (Sch 13521). Arzneimittelforschung (1977) 0.75
[Effect of herbicides--derivatives of chlorphenoxyacetic acid on human and animal organism. (Literature review)]. Farmakol Toksikol (1970) 0.75
[Activity of hepatic nonspecific oxidases and the biological effects of antitumor preparations]. Vestn Akad Med Nauk SSSR (1981) 0.75
[Effect of sarcolysin and embikhin on neutral red sorption by some organs and tumors in rats]. Farmakol Toksikol (1970) 0.75
[High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children]. Vopr Onkol (1990) 0.75
Design of cancer chemotherapy: tailored sensitivity assays. Antibiot Chemother (1971) (1980) 0.75
[Analysis of deletions in the dystrophin gene in patients with Duchenne muscular dystrophy in the Bashkir Republic]. Genetika (1999) 0.75
[Hygienic assessment of ambient air pollution in the industrial towns of the Republic of Karelia and that of a risk to the health status of pediatric and adolescent populations]. Gig Sanit (2008) 0.75
[Risks occurring during the use of raw medicinal plant material and its based phytopreparations]. Gig Sanit (2011) 0.75
[Assessment of human health risk in the substantiation of managerial town-planning decisions]. Gig Sanit (2004) 0.75
[Hygienic aspects of a human health-hot water supply quality warm relationship]. Gig Sanit (2005) 0.75
[Antineoplastic effect of asalin and asaleĭ during multiple and single enteral, intramuscular and rectal administration]. Farmakol Toksikol (1972) 0.75
[Hyperbranched polylysines modified with histidine and arginine: the optimization of their DNA compacting and endosomolytic properties]. Bioorg Khim (2009) 0.75
Preclinical study of antitumor compounds. Natl Cancer Inst Monogr (1977) 0.75
[The results of removing a transparent lens in Marfan's syndrome]. Oftalmol Zh (1989) 0.75
[Evaluation of the therapeutic effectiveness of likurim in lymphosarcoma in dogs]. Gematol Transfuziol (1984) 0.75
Effect of cross linkers on the bacteriorhodopsin photocycle. Biochem Biophys Res Commun (1987) 0.75
[The need for developing a methodology of spatial rationale for a sanitary protective zone]. Gig Sanit (2007) 0.75
[The influence of calcium N-(5-hydroxynicotinoyl)-L-glutamate on reproductive function, prenatal and postnatal development of rats]. Eksp Klin Farmakol (2012) 0.75
[Blastolysin, an agent potentiating the antitumor action of ionizing radiation]. Dokl Akad Nauk SSSR (1980) 0.75
[Role of immunity in the action of sarcolysine and other preparations]. Vestn Akad Med Nauk SSSR (1971) 0.75
[Development of oncological research performed at the dissertation level 1976-1980]. Vopr Onkol (1983) 0.75
[Hygienic basis for combined models assessing occupational risks]. Med Tr Prom Ekol (2009) 0.75
[Impact of the environmental factors on the incidence of thyroid diseases in the population of the Nizhniĭ Novgorod region]. Gig Sanit (2009) 0.75
[A study of the antitumor effectiveness of endoxan when administered in various ways]. Vopr Onkol (1969) 0.75
[Comparative evaluation of the results of preoperative ultrasonic diagnosis and ophthalmoscopic data acquired at the time of and following vitrectomy in patients with intravitreal hemorrhage]. Oftalmol Zh (1985) 0.75
[Comparative analysis of methods for calculating the average inhalational exposure loads in the assessment of health risk]. Gig Sanit (2006) 0.75
[Toxicity of N-acetylsarcolysin peptides following diverse routes of administration]. Farmakol Toksikol (1972) 0.75
[Histiocytosis-related proliferative disorders in children]. Vopr Onkol (2000) 0.75
[Expression of the human dystrophin gene in mdx mouse skeletal muscles after ballistic transfection]. Genetika (1998) 0.75
[Experience of the implementation of the method of the integral assessment of drinking water on indicators of chemical harmlessness in St. Petersburg]. Gig Sanit (2013) 0.75
[Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use]. Antibiotiki (1976) 0.75
[Bioelectrical activity in the sensorimotor cortex in rats with pain syndrome of the spinal origin]. Biull Eksp Biol Med (1999) 0.75
Proposal of a high-field superconducting wiggler for a slow positron source at SPring-8. J Synchrotron Radiat (1998) 0.75
[Toxicity and cumulative properties of actinomycins C1, C2 and C3, contained in preparations in various combinations]. Antibiotiki (1971) 0.75
[General anesthesia using diprivan in patients with lesions of the locomotor system in a day hospital]. Anesteziol Reanimatol (1998) 0.75
[Antineoplastic and immunodepressive activity of purinylglutathionyl disulfide]. Farmakol Toksikol (1972) 0.75
[New concepts of microsomal metabolism of the antibiotic adriamycin]. Bioorg Khim (1985) 0.75
[Clinical course and prognosis in T-cell lymphoblastic tumors in children typed with Soviet-produced monoclonal antibodies]. Gematol Transfuziol (1990) 0.75
Mast cell regulatory effect on lymphoid cell proliferation. Agents Actions (1991) 0.75
[Clinical aspects and treatment of recurrences of lymphosarcoma in children]. Pediatriia (1991) 0.75
Effect of akatinol (memantine) in central spinal pain syndrome. Bull Exp Biol Med (2000) 0.75
[Treatment and prognosis of lymphoblastic lymphosarcoma in children]. Pediatriia (1991) 0.75